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Abstract: Dementia disorders are increasingly becoming sources of a broad range of 
problems, strongly interfering with the normal daily tasks of a growing number of 
individuals. Such neurodegenerative diseases are often accompanied with progressive brain 
atrophy that, at late stages, leads to drastically reduced brain dimensions. Currently, this 
structural change could be followed with X-ray computed tomography (XCT) or magnetic 
resonance imaging (MRI), but they share numerous disadvantages in terms of usability, 
invasiveness and costs. In this work, we aim to retrieve information concerning the brain-
atrophy stage and its evolution, proposing a novel approach based on non-invasive time-
resolved near infra-red (tr-NIR) measurements. For this purpose, we created a set of virtual 
human-head atlases in which we eroded the brain as it would happen in a clinical brain-
atrophy progression. These realistic meshes were used to simulate a longitudinal tr-NIR 
study, investigating the effects of an increased amount of cerebral spinal fluid (CSF) in the 
photon diffusion. The analysis of late photons in the time-resolved reflectance curve–obtained 
via accurate Monte Carlo simulations–exhibited peculiar slope-changes upon CSF layer 
increase. The visibility of the effect under several measurement conditions suggested good 
sensitivity to CSF variation, even in the case of real measurement and under different 
geometrical models. The robustness of the results might promote the technique as a potential 
indicator of the dementia progression, relying only on fast and non-invasive optical 
observations. 
© 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement 
1. Introduction
In modern societies, demographic changes related to population ageing are already exhibiting 
dramatic impact from a personal, societal and economical point of view. Invalidating diseases 
slowly and inexorably push the sufferers and their families at the edge of the society, allowing 
little possibilities to maintain decent life expectations. Medical science and closely related 
research fields are currently pursuing a broad counter attack to such health issues, aiming at 
the full comprehension and cure of the sickness. A clear understanding of the disease 
generation and its evolution are key-points for reducing, alleviating or arresting the 
progression of the illness, thus helping the individual to return back to a normal-life 
condition. 
In this scenario, generic Dementia symptoms –that progressively impair mental abilities– 
are one of the most difficult enemies to tackle. Accounting for 60-80% of the total cases 
diagnosed, the Alzheimer’s disease (AD) is the most common type of dementia, followed by 
vascular dementia (VD), dementia with Lewy bodies (DLB), Parkinson’s disease (PD), 
normal pressure hydrocefalus (NPH), frontotemporal dementia (FTD) and other rarer 
conditions [1,2]. At the moment, this class of diseases have no cure nor a clear 
comprehension of the phenomena behind their evolution. Moreover, there are no validated 
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ways to diagnose them –especially at early stages– and neither a way to arrest (or prevent) the 
disease progression. Several ongoing researches have selected potential biomarkers which 
exhibit good ability to indicate early stage of the dementia disorders. Brain imaging [3–5], 
amyloid-PET imaging [6], presence of proteins in cerebral spinal fluid (CSF) [7–9] or in 
blood [10] and genetic risk profiling [11] are exceptionally good candidates, but at the 
moment they lack in general validation. Almost all of them rely on invasive procedures to 
evaluate the markers: Contrast agent injection [12], CSF sampling from the spinal cord [13] 
or blood sampling [5,14] are the typical diagnostic options. Not only they are invasive, but 
they also rely on x-ray computed tomography (XCT), positron emission tomography (PET), 
magnetic resonance imaging (MRI) measurements or post-sampling chemical analysis: in 
general, these procedures are slow in measuring/interpreting the results and definitely very 
expensive for the healthcare system. 
There is –without any doubt– a clinical need for a fast and easy way to detect, monitor and 
follow in time the disorders, helping Dementia research to reach a wider number of patients. 
Apart from monitoring symptoms of memory loss and difficulty in performing normal every-
day tasks, one of the less invasive way to follow the dementia progression is the MRI-
estimation of the cerebral atrophy. In fact, brain volume reduction is associated with many 
kinds of dementia such as in AD [3,4], NPH and FTD [15]. In turns, the disease progression 
implies the increase of CSF volume circulating in the braincase, compensating the reduction 
of the brain in specific regions. Such fluid plays the role of nutrient vector and mechanical 
cushion for the brain, having the potential to be one of the most reliable biomarker for the 
diagnosis of dementia disorders. In particular, the analysis of the CSF can report traces of 
beta-amyloid plaques developing on the brain external cortex when the AD progresses, 
leading to a quite reliable tool for the diagnosis of this disease. Interestingly this fluid –
constituted by 99% of water– results to be optically transparent in the visible and near-
infrared range, having almost negligible absorption and scattering coefficients. In these terms, 
a generic dementia development could be seen as a volume-increase of non-scattering regions 
within the head that would strongly affect the photon diffusion within the tissues, as already 
proven by several works on the fields [9,16,17]. 
In our work, we examine the possibility of retrieving information connected to the CSF 
variation -in the case of a generic dementia-related disorder- by making use of fast optical 
non-invasive techniques. Specifically, we will show how time-resolved near infrared (tr-NIR) 
measurements have the potential to extract information about the presence of the disease, 
being effectively capable of monitoring its development. Carrying on such kind of studies 
requires careful design and important investments that must be evaluated in advance, in order 
to estimate the impact of the proposed research. To do so, we propose a computational 
approach to study the visibility of the dementia evolution via optical techniques. We will 
firstly approach the schematization of brain atrophy progression (BAP) in two geometries: a 
simple cylindrical model with parallel layers and a more complex human-head atlas. Then we 
make use of Monte Carlo (MC) photon propagation technique to simulate the results of a 
hypothetical longitudinal experiment on a human being. The goal is to exploit modern optical 
imaging techniques aiming at the definition of a novel way to monitor dementia diseases, 
with less expensive and non-invasive laser-based measurements. Explicitly, MC simulations 
are designed to replicate exactly a tr-NIR measurement, in which photons are probed into the 
human body and their reflected signal is detected from the same side. In such a way, it is 
possible to estimate the distribution of time of flight (DTOF), which carries important 
information about the photon diffusion within the underlying tissues. From the results 
obtained by running MC simulations while changing the brain volume, we expect to 
appreciate and characterize variations in the DTOF, thus linking these features to the disease 
progression. 
Although many types of dementia imply brain atrophy, we will refer to the specific case 
of the AD in which the whole brain shrinks due to a surface erosion mechanism. The same 
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results could be extended to study other neurodegenerative diseases by taking into account 
more specific brain modifications, such as for example FTD and NPH. Furthermore, these 
studies could be of interest also for the detection and monitoring of hydrocephalus, where 
recent reports have demonstrated the possibility to detect such alterations by frequency-
domain NIR (fd-NIR) measurements. Potential for assessing these alterations and monitoring 
drug therapy in low income countries is particularly fascinating [18]. This work, in fact, takes 
inspiration on recent computational studies on the role of CSF in photon propagation [19–21] 
and novel understandings in AD progress prediction [22]. 
2. Strategies to model brain atrophy
To mimic the disease evolution, we realized two different structural models making use of the 
mesh generator software iso2mesh [23]. As we already mentioned before, we focus our 
analysis mainly on dementia diseases that imply generalized neuronal atrophy affecting the 
external surface of the brain, leaving more specific structural effects as a further discussion. 
Without loss of generality, we will refer to this kind of degeneration as an ideal AD 
progression [24], which represents a large 80% of the total cases of diagnosed dementia in 
patients. 
2.1 Brain atrophy progression assumption 
In the current literature, no structural meshes are available to model the BAP of any dementia 
disorder. To compensate for the lack of models, we decided to create a set of atlases 
mimicking the AD progression. The creation of the models is grounded to a simple 
assumption, which is also one of the best candidates for the indication of the diseases itself: as 
the AD progresses, the brain starts losing neuronal tissues and its volume shrinks [16,17]. The 
effect associated with such tissue loss is that the grooves start to widen and the ridges get 
narrower [25], as if the tissue were eroded from its outer surface. Remarkably, the human 
body contrasts this cerebral-loss by filling up the empty volume left in the subarachnoid space 
with more CSF, increasing the thickness of the region where the fluid circulates. This is 
outright visible in MRI or XCT scans of the human head affected by the various kind of 
dementia [2,25] and promotes CSF variations as one of the possible biomarkers indicating the 
presence of the disease. 
Fig. 1. Infographic showing a combined view of the cylindrical 4-layer mesh volumes used in 
the simulations and the locations of source and detectors on their top layer. Preserving the Skin 
& Skull and the Gray Matter thickness, a linearly increasing CSF layer is inserted in between, 
representing a hypothetical Alzheimer’s progression (or, in general, any brain-atrophy 
dementia-related disorder). 
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2.2 BAP in a cylindrical model 
The use of layered samples with optical properties similar to those of the tissues of interest is 
a simple approach to study the photon diffusion within a biological sample. For this purpose, 
we created several 4-layered cylindrical mesh volumes, considering each layer as a different 
tissue: Skin and Skull (SS) as a unique entity, CSF, Gray Matter (GM) and White Matter 
(WM). The diameter of the cylinder is set to 100D mm= . In each mesh, the SS and GM 
tissues always have the same thickness, while the CSF increments in size to mimic the AD 
progression. The WM tissue was decreased to keep constant the total height of the cylinder, 
set to be 60 mm . We assume that no photons will trespass the cylinder, due to the very high 
scattering properties of the WM region. In total, we considered seven CSF thicknesses 
ranging from 0.0 mm  to 15.0 mm  in steps of 2.5 mm , which are shown at a glance in the 
infographic of Fig. 1. On top of the SS surface we inserted 280 nodes, arranged in a 
concentric fashion. Each node defines the location of a time-resolved photon detector, 
forming 7 ring-arrays constituted by 40 photon counters. The distance between each ring is 
increased in step of 5 mm , having interfiber distances ranging from 10 mm  to 45 mm . Each 
detector has a photon acceptance radius of 0.75 mm  and a total recording time window of 
6 ns  from the moment of the launch. A pencil beam source impinges in the center of the 
mesh and the resulting detection functions are stored for each of the different meshes. The 
results obtained from all the detectors located at the same S-D distances are integrated –due to 
the bi-dimensional isotropicity of the cylindrical model– increasing the signal to noise ratio 
by a factor of 40 . This is a common averaging approach used in simple geometries such as 
in Monte Carlo Multi Layered (MCML) [26]. 
Table 1. Tissues optical properties used in the simulations. The same tissue optical 
properties are used for both the cylindrical and the human head model. The last column 
shows the thickness IDT  of the layers used in the Cylindrical Model. For the CSF we 
examined two different scattering coefficients in this study. 




1[ ]−mm  
g n  IDT  [ ]mm  
SS Skin and Skull 0.019 7.800 [27] 0.89 1.40 12.5
CSF Cerebral Spinal Fluid 0.004 
0.009 [27] 
0.1 [28] 0.89 1.40 
Variable [0.0,1 5.0]∈  
step variation = 2.5 
GM Gray Matter 0.020 9.000 [27] 0.89 1.40 4.0  
WM White Matter 0.080 40.900 [27] 0.84 1.40 60.0 ( )ss CSF GMT T T− + +
2.3 BAP in a realistic human head model 
Although planar layered phantoms are commonly used to compare and test experimental 
measurements, the availability of more accurate models can be useful to understand the role 
of geometrical structures in the photon propagation [21,29]. Currently, one of the most 
accurate human-head mesh structure is the Colin27 model [30,31], composed by a 4-tissues 
atlas. On the other hand, nothing similar exists for modelling a patient exhibiting BAP at 
different temporal stages. The lack of such interesting models is compensated in our work by 
the creation of several meshes progressively reducing the brain dimensions. Since dementia-
related phenomena evolve by eroding the brain structure, we decided to perform this 
operation directly on the WM and GM regions of the Colin27 mesh. Firstly, we separated the 
four tissues of the model, neglecting the inner closed surfaces in the brain that represent the 
ventricular cavities. For our specific purpose, there is no hope to detect photons reflected 
from such deep structures. The surface meshes extracted are enclosing each other with the 
same order as in the cylindrical model: starting from the outer layer toward the inner one we 
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find the SS, the CSF, the GM and the WM. Each closed-surface was converted into a binary 
volume with an isotropic voxel (3D cubic pixel unit) resolution of 0.02 mm  in the three 
spatial dimensions, then the enclosed regions were filled. From now on, we abbreviate voxel 
as “ vx ”. The result of this operation returns four volumetric data sets containing the atlases 
of each structure considered. Two of them were left unaltered, SS and CSF regions, since the 
external shape of the scalp and the inner surface of the skull are not structurally affected by 
the AD disease. Every modification that follows was performed on both GM and WM binary 
data sets. Since the disease progression is associated with the loss of brain matter, we decided 
to operate in the exact same way as AD acts, aiming at miming the eroding nature of the 
disease. 
A binary erosion-operator [32] was applied to both GM and WM volumes, eroding the 
tissues with different structuring elements. Using first neighborhood erosion (cubic and 
diamond structuring elements in Fig. 2) resulted to be a bad choice: single point cavities in 
the brain, such as small foldings and grooves, started developing into artifacts similar to the 
structuring element used. The top panel of Fig. 2 shows what happens by eroding with such 
structures, where squared or triangular cavities start to be clearly visible at later erosion 
stages. Instead, spherical-like structuring elements gave smoother results, preserving the 
original curvature of the foldings at the exterior brain surface (Fig. 2, bottom part). In this 
preliminary study, we consider the latter to be a good approximation to model the brain 
erosion mechanism behind dementia diseases. 
We point out that it is not possible to proceed stepwise (1 voxel erosion at each step) and 
the diameter in the spherical erosion core has to be greater than 4 D vx= . In fact, choosing 
1 ~ 2 D vx=  gives rise to cubic artifacts and 3 D vx=  has diamond evolution. In general, the 
larger the D  of the spherical structuring element, the smoother will be the erosion. In our 
work, we used erosion with spherical structuring element of diameter 6 1.2 D vx mm= =  
generating 11 meshes that mimic hypothetical stages of the disease. The whole process took 
around 2-5 minutes per mesh with a normal PC equipped with a CPU intel i7-4930K and 32 
Gb of RAM depending on the BAP stage. More advanced stages have less nodes on the GM 
and WM surfaces and the meshing time decreases. 
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3. Results
In general, light transport within any biological tissue is mathematically described by the 
Radiative Transport Equation (RTE) [35]. Exact analytical solutions for the RTE are 
accessible only with simple geometries or with Diffusion Equation (DE) approximation [36], 
whereas for complex shapes other approaches should be taken into account to correctly infer 
the photon propagation. Among the others, the Monte Carlo (MC) photon propagation 
method statistically provides an accurate solution for the RTE for a high number of injected 
photons [37]. Because of this, it is considered the gold-standard method for modelling the 
photon diffusion within biological tissues and it is currently widely used as a predictive tool 
in the optical imaging community [28,35–39]. Thanks to modern paradigms in CPU and GPU 
computing, Monte Carlo (MC) simulations [27,40] are becoming a feasible choice for 
modelling the photon diffusion within biological tissues. In this study, we took advantage of 
one of the most recent and accurate Monte Carlo simulation tool for the photon propagation, 
the Mesh-based Monte Carlo (MMC) [27], to resolve the photon diffusion within the human-
head model. A total of 101.1 10⋅  (eleven billion) photons were launched, with an average 
running time of 10 hours to propagate 910  (one billion) photons per each AD models. We are 
aware that tissues’ optical properties might vary among different individuals or throughout 
the disease process, and hence we studied two different scattering coefficients for the CSF. As 
reported in Table 1, we used extremal values taken from relevant bibliography [27,28] 
differing each other by one order of magnitude, to be able to comprehend how the results 
differ with an eventual change of such parameter. In the following, we analyze the results 
obtained for the cylindrical and human-head meshes, focusing on the possibility of 
monitoring the disease evolution in time in a realistic laboratory measurement scenario. 
3.1 Results of BAP in the cylindrical model 
Already with the cylindrical model for the AD we obtained interesting results from the photon 
diffusion within the phantom. In Fig. 6, we plot the distribution of time of flight (DTOF) –
also called time-resolved diffuse reflectance– measured at various interfiber separations. 
Although we sampled also at other distances, we do not plot the results at intermediate values 
(15 mm , 25 mm , 35 mm ) since they would be visually redundant and not adding further 
information. It is visible from the graphs that increasing the CSF thickness does not turn into 
any interesting variation at early detection times, with an exception at S-D = 40mm having 
CSF thinner than 5mm. This is not surprising since the early photons have been spending 
most of their time in the superficial SS layer. 
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Fig. 6. Distribution of time of flight (DTOF) at four interfiber source-detector (S-D) distances 
for the cylindrical layered phantoms at various CSF thicknesses. On the left column, the raw 
data considering an ideal response of the detector, on the right the corresponding curves 
convolved with a typical instrument response function (IRF). In the first plot are marked the 
temporal windows considered as early-photons (green) and late-photons (red) gating. 
This happens at short S-D separations (10 mm  to 20 mm ) because the reflectance curve of 
each AD model shares the same trend with the Control model without CSF. At longer 
distances ( 25 mm  to 40 mm ) instead, the AD and Control models start to diverge, suggesting 
contributions from deeper tissues. In general, at early times and at long S-D separations, it is 
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remarkable the fact that all the AD models are not distinguishable between each other, with 
the only exception being S-D = 40mm with CSF<5mm. This implies that the photons 
reaching the CSF-level delay their way back to the detection side, pushing the variations of 
the DTOF curve at middle-late timing. 
Due to the above reasons, we do not appreciate any visible shift of the response peak (Fig. 
7, panel A), which variates at different S-D distances but does not between the ADs and 
Control models at given interfiber distance. All the DTOF at different CSF thicknesses are 
practically overlapping: a weak effect starts to appear at longer S-D distances that we do not 
consider relevant in this study. On the other hand, the effect of the convolution with the IRF 
is shown in panel B of Fig. 7. In this case, the temporal shift is expressed as the delay in time 
of the convolved DTOF curve with respect to the IRF peak, located at 240 ps  in the curve or 
Fig. 6. Like in the ideal case, no perturbation is observed after the convolution while 
increasing the CSF thickness. The light-red regions in Fig. 7(A)-(B) represent the confidence 
band of the results obtained by considering a less scattering CSF layer. 
At middle timing (1000 ps  to 2500 ps ), the DTOF response is found to be in an 
intermediate regime, in which photons reflected at a deeper level start to be seen from the 
detectors. More interesting, instead, is the situation arising from the analysis of late-timing 
response curve ( 2500 ps> ). At such long times, the photons have the ability to trespass the 
SS layer and reach the CSF. In this quasi-clear optical environment, light propagates in a 
nearly-straight fashion and the time of flight increases proportionally to the size of the CSF. 
At late times, in fact, the variation of the size of the CSF turns into a change in the slope of 
the DTOF that loses its steepness while thickening the clear layer. This fact is evident in 
every plot of Fig. 6. Panel C of Fig. 7 reports the slope variation at late-timing due to the 
increased thickness of the CSF layer (solid line for strong scattering, dashed lines for weaker). 
We found a steep slope-change at short CSF variation for both the values of the scattering 
coefficient examined, suggesting higher sensitivity at early BAP. Remarkably, the detection 
at different S-D separations returns approximately a constant function slope, which we plot as 
a confidence gray band (and light-green for lower scattering). We conclude that this is a direct 
feature introduced by the CSF thickness and it might be exploited as a differential measure to 
estimate the brain shrinkage. 
Fig. 7. CSF fingerprints in the cylindrical model. On the left panel A), the peak response 
delays as a function of the S-D separation and it resulted to be equal for all the CSF 
thicknesses investigated. On panel B, the corresponding response delay after the convolution 
with the IRF that introduces a uniform temporal peak-delay. On the right panel C), the 
changing in the slope of the late photons due to increased CSF thickness. 
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Fig. 8. DTOF curves at various Source-Detector separations for the human-head models. 
Compared to that of cylindrical models, the measurements are noisier due to the impossibility 
of averaging many detector responses for the lack of symmetry in complex geometries. The 
left column shows the raw data sets, on the right the corresponding convolution with a realistic 
IRF. 
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The considerations about the slope measurement arising with a real IRF are even more 
interesting (Fig. 7 panel C, data presented with filled or empty circles). Even after the 
convolution, we can appreciate that the slope of the response function still falls into the 
confidence band. The response of the measurement system, then, is not compromising the 
possibility to estimate the thickness of the CSF layer, since simulations and realistic 
measurements (affected by IRF) displayed the same trend. 
3.2 Results of BAP in the human-head model 
So far, we examined the behavior of an ideal cylindrical layered volume under virtual tr-NIR 
experiment; but our recent work in continuous wave regime [21] pointed out that the 
anatomical conformation of the CSF might play an important role in the photon propagation. 
It is worth to examine any possible shape-induced effect also with time-domain 
measurements, comparing the results of the cylindrical model with those obtained with more 
detailed human-head atlas. 
We impinge the same laser source on the right head hemisphere as described in Fig. 4, and 
we collect the detector responses in the same way we did for the cylindrical phantom. In this 
case, we cannot sum over detectors located at the same S-D separation due to the not 
symmetric shape of the human head. We performed the same simulation for every AD model 
created, but in Fig. 8 we plot only the DTOF obtained for Stage 0, 2, 4, 6, 8 and 10 in order 
not to compromise the readability of the graphs. For the sake of completeness, we report that 
the intermediate results followed a continuous trend. 
Fig. 9. Features of the response curves for the Human Head models. A) There is no evident 
peak shift in the response curves at early detection times as a function of the CSF. The peaks 
are so close to each other that in the plot all the curves are overlaying each other. B) Even the 
convolution with the IRF, which shifts up the peak response in time, does not introduce any 
further visible effect in the measurements. C) Slope variation for late-photons detection as a 
function of the CSF thickness. In the plot is possible to notice how increased thicknesses of the 
transparent layer surrounding the brain will affect the reflectance curve, giving useful hints 
about the possibility to estimate its average thickness. 
Surprisingly, the situation is pretty similar to what we obtained in the cylindrical models. 
Also in this case, there is no appreciable shift of the peak response at different CSF thickness, 
due to the fact that the photons contributing to early-time detections are travelling mostly in 
the superficial region of the SS tissue. As expected (Fig. 9, panel A), increasing S-D 
separation progressively delays the signal-peak, while IRF-convolution does not introduce 
any effect on such delay (panel B). Similarly to what observed in the cylindrical model, the 
slopes of the DTOF are directly affected by the CSF thickness with approximately uniform 
sensitivity at every stage of the atrophy progression (Fig. 8, panel C). Interestingly, one order 
of magnitude change in the optical properties of the clear layer does not vary the sensitivity of 
the slope-curve, which follows the same trend for both the sμ  analyzed (gray and light-green 
confidence band in panel C). Even if the general results are congruent with those obtained 
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using cylindrical phantoms, the absolute values are different. Most likely this is because the 
CSF region is now a complex surface with grooves and foldings, which complicates the 
photon-path if compared to that of normal planar surfaces. Moreover, the relative size of the 
layers is approximately similar but not exactly matching, leading to different delays in the 
reflected signal. The convolution with the IRF turned into the same behavior described in the 
previous paragraph and does not influence the overall slope of the late-timing DTOF curve. 
This suggests that even in the more realist case of a human head, the chances to appreciate 
internal CSF variations are not compromised by using a real instrument. 
4. Discussion
As we already discussed throughout the text, AD and other dementia problematics generically 
involve a variation of the brain-volume due to the neurodegenerative process that leads 
neurons to commit apoptosis. Although the biological mechanism is not yet clarified, such 
variations are always connected with the shrinkage of the GM and WM constituting the brain 
and, in particular, express themselves as a complex change on the brain cerebral cortex. This 
surface-erosion implies specific modifications, turning into a widening of the grooves and 
narrowing or the ridges typical of the neuroanatomical structure of the brain. Ventricular 
cavities are also affected by the neuron-loss connected with the disease, forcing an expansion 
of their chamber-volume. During the disease progression, the brain is effectively reducing its 
size inside a fixed braincase and the space left-over is filled with an increased amount of CSF. 
This is a physiological reaction that tries to preserve the mechanical and immunological 
functionalities of the CSF surrounding the diseased brain. From a structural point of view, the 
brain changes its relative mean surface-distance with respect the internal skull-walls, since the 
neurocranium does not vary appreciably in shape (especially in normal elderly individual). 
This is functional to the progression of the neurodegenerative process and it is an important 
parameter for assessing the health condition of a patient. At the moment, the techniques that 
could give structural information about the dementia progression are limited to the costly and 
non-portable MRI or to the radiation-exposing XCT. Despite their adequate imaging 
resolution for the detection of structural changes, time-resolved monitoring of the disease is 
not yet affordable due to high risks connected with repetitive ionizing radiation or –more in 
general– with the high cost that such study would imply. 
In our work, we tried to tackle the current blindness in longitudinal studies of structural 
disease evolution by exploring the possibility offered by harmless tr-NIR measurements. To 
understand the role played by the CSF in the DTOF response curve, we created ad hoc 
detailed mesh-models that replicate the structural disease evolution in time. The absolute lack 
of systematic studies of this evolution was updated by the creation of different cylindrical and 
human-head meshes modelling the disease progression in time. A simplistic study in 
cylindrical geometries with varying CSF thickness was complemented with the reproduction 
of an AD model that realistically mimics the brain atrophy, to analyze the role of complex 
structural conformations. To create these detailed human-head models we took advantage of 
modern meshing tools [31], which we exploited to implement an erosion algorithm 
reproducing the brain-shrinkage. We started from the Colin27 model [30], eroding the gray 
and white matter via an iterative process based on voxelization and and re-meshing the atlases 
at different stages. With these new human-head structures we do not have the ambition to 
reproduce an exact model of the AD development: they offer the opportunity to predict a 
general trend of realistic tr-NIR measurements, keeping an eye at the nature of the BAP. In 
fact, our erosion method preserves the complex structure of the brain surface, with grooves 
and ridges evolving similarly to the neurodegeneration in a real individual affected by 
dementia [2,25,33]. Of course, further details could have been taken into account, such as the 
modelling of the ventricle size variation, but at the first step of our work there is already a 
broad spectrum of useful information arising from this study. 
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Here we tried to obtain general results, parametrizing the CSF with two different 
scattering coefficients: firstly considering it as a nearly transparent and non-scattering layer 
[27] then having more turbid optical properties [28]. This is an important test, since tissues’
optical properties might vary among different clinical cases or at various BAP stages: we
want to make sure that changes of the scattering coefficient of the CSF do not perturb the
generality of the conclusions.
Fig. 10. Statistical noise of the MC simulations until 4000 ps. Coefficient of noise-variation of 
the standard deviation error with respect the average DTOF curve for the cylindrical model A) 
and for the human head B). The noise is always below 5% until 4000 ps and does not depend 
upon CSF variations. 
A great number of MC simulations of ideal tr-NIR experiments were run during this 
study. Each virtual experiment was composed of 10 partial simulations obtained propagating 
810  photons, in order to have a sufficient number of DTOFs for statistical analysis. The 
standard deviation of each curve in Fig. 6 and 8 was divided by their average, obtaining the 
coefficient of noise-variation of the MC simulation. In Fig. 10 we report the analysis of the 
curves measured at 30 mm  interfiber distance with Strangman’s parameters, but similar 
results were obtained at all the S-D separations. In the cylindrical model (panel A) all the 
simulations are affected by a statistical uncertainty that is always smaller than 5%, while in 
the human head model (panel B) the noise grows bigger than 5%  after 4000 ps . Such a 
small statistical noise gives enough accuracy for calculating the DTOF slope between 
2500 ps  and 4000 ps . Interestingly, changing the CSF does not add any visible effect in the 
noise-trend that seems to be related only to pure measurement conditions rather than 
geometrical variation. This drives us to the assumption that the MC simulations have the 
same sensitivity at each BAP stage and all the results that we will discuss in the following are 
comparable with each other. 
On the other hand, the DTOF curves calculated with the detectors resulted to be sensitive 
to CSF thickening, but interestingly only few features were influenced by the change of the 
clear layer. Firstly, we found that increased level of CSF does not introduce any significant 
peak-shift of the DTOF (Figs. 6-8). Moreover, at early times, all the curves with different 
CSF thicknesses are very similar to the other making impossible to distinguish them (Figs. 7-
9 panels A). Not even the convolution with an experimental IRF modified this trend, thus 
suggesting that a real measurement would not introduce any unwanted artifact (Figs. 7-9 
panels B). These facts indicate that the disease evolution cannot be seen at early photon 
gating, because the light did not sufficiently explore deeper tissue regions. More interesting is 
the analysis of late-photons (starting at around 2500 ps ) where the DTOF starts to exhibit a 
linear decay (in logarithmic scale, Figs. 6-8). In this case, the shrinking of the brain region 
visibly changes the slope of the detector response (Figs. 7-9 panels C). Higher thicknesses of 
the clear layer correspond to less steep slopes, suggesting that following its variation could 
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help monitoring the disease evolution or the assessment of its stage. More interestingly, this 
effect seems not to be affected by the IRF convolution that exactly preserved the slopes (Figs. 
6-7 panels A-B), further increasing the chances to use it as biomarker in realistic laboratory
measurements. It is worth to notice that the slope –at late gating– does not vary at different
interfiber S-D separations, possibly giving the opportunity to consider averaging different
response curves in case of noisy measurements.
Remarkably both cylindrical and human models behaved in a similar fashion with respect 
to the slope variation: increasing the thickness of the CSF flattens the slope of the DTOF at 
late time gating. On the other hand, our previous work on fluorescence molecular tomography 
(FMT) [41] shown that the size of the CSF had no role in the photon diffusion process in a 
cylindrical model. In that case, the models were insensitive to thickness variation, up to the 
point that the transparent layer could have been neglected without losing accuracy. On the 
other hand, in a more realistic mouse-like model [42], the inclusion of the CSF affects the 
simulation output, turning into artifacts that are not possible to normalize [21]. Depending on 
the geometry of the model and the measurement scheme employed, clear tissues exhibit 
different behaviors that must be singularly evaluated. 
In this study, the trend followed was the same for both the models and the optical 
parameters: the logarithmic DTOF after 2500 ps  followed a linear decay, decreasing its slope 
steepness while increasing the CSF volume. On average, the absolute difference of the slope 
variations between the models was around 35% , suggesting that the models were sensitive to 
the CSF’s structure and to its optical parameters. At this stage, the results clearly demonstrate 
a significant effect caused by the progressive brain atrophy on the shape of the DTOF. 
Whether these alterations are detectable or distinguishable from physiological variations in 
healthy subjects, is yet to be addressed. It is out of the scope of the present study to 
investigate effective strategies to disentangle healthy from diseased subjects, or at least to 
longitudinally monitor the very same subject over time. In principle, as compared to other 
locations as the forearm or the abdomen, the head geometry is rather fixed over time and 
chances to track internal changes could be viable following the approach proposed. 
5. Conclusions
Some remarkable facts emerged from this study. For the first time we approached the 
problem of the creation of complex human head atlases with variable CSF thickness, 
mimicking biological tissue variations comparable with that of dementia related diseases. 
Although complex, the protocol that we followed is quite linear and could be also tuned to 
describe some more specific brain variations, such as temporal-lobe atrophy (in the FTD) or 
enlarging ventricular cavities (in the NPH). Moreover, MC photon propagation seems to be 
the natural choice to perform such study: other approaches would have neglected the presence 
of the CSF layer [43] or approximated it with radiosity theory [44], inserting unpredictable 
perturbations to the model. Instead, MC is often considered as a gold standard for the 
simulation of the photon flux in biological tissues and let us retrieve important information 
about the effect of CSF in a realistic tr-NIR measurement. Late photons, shown an interesting 
slope-change in the DTOF that does not depend on the interfiber distance but rather on the 
CSF thickness itself. If measured in longitudinal studies, such slope change could give 
precious information about the disease stage and the velocity of its evolution, thus opening 
new paths towards the understanding of the disease mechanisms. On the other hand, late 
photon gating ( 2500 ps> ) might be difficult to achieve in real systems with acceptable SNR 
but progresses in the creation of more efficient detectors are pushing this limit further towards 
late-photon analysis [38]. At the moment, we notice that the convolution with an 
experimental IRF did not influence the results, thus promising a certain degree of accuracy 
retained also at experimental level. Of course, further investigations could be done by taking 
into account other IRFs of various detectors, but this would have exceeded the purpose of this 
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study. The detector considered in the experiment, in fact, is fast compared to the details of the 
DTOF. However, detectors exhibiting a slowly-decaying tail could influence differently the 
DTOF at late times. This might worth further investigations in the case of availability of 
specific hardware, even if the rapid development of detector technology is pushing toward the 
achievement of faster responsivity. Lastly, results obtained with a realistic head model and 
with a simpler layered structure were comparable, showing the same trend for the slope-
change effect at late gating. Even if quantitatively differing from each other, this reinforces 
our belief that slope variation is tightly connected with the average CSF thickness rather than 
local structural conformations. 
All these considerations leave us with a promising perspective for the real implementation 
of this procedure, making our results more general and weakly depending upon exact 
anatomical surface features. To extract such details in fact, MRI and XCT measurement are 
still the gold-standard, but hints regarding the CSF thickness-change are likely to be captured 
also by faster and non-invasive tr-NIR measurements. Although our study is broad, a lot more 
could be done in the near future, to further investigate the behavior found in our simulations. 
Not only real experimental tests are on our future plan, but also new simulations are on the 
way to test different and possibly more accurate methodologies. In fact, it might be worth 
considering an eventual change of scattering coefficient of the CSF during the disease 
progression, both in terms of optical turbidity or structural-induced anisotropicity 
(considering, for example, the arachnoid trabeculae strands present in the subarachnoid space 
where the CSF circulates). Unfortunately, at the moment there are no dedicated studies 
supporting this further investigation. Among others, tr-NIR Spectroscopy (tr-NIRS) is a major 
candidate from which we could extract further information as a function of the wavelength. In 
particular, seems interesting the exploitation of the complex absorption landscape of the water 
to obtain a reference curve independent on the CSF thickness. Our goal, in fact, is to open up 
the possibility of tr-NIRS imaging for neurodegenerative monitoring. For these reasons, we 
believe our contribution to the biomedical imaging field to be of renewed interest for the 
dementia-research community. With this work we hope to foster novel strategies for the 
definition of non-invasive biomarkers, aiming at a better understanding of the dementia 
diseases and –possibly– towards a better care of the patient. 
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